1 April 2024 v2025.76.1 limited_company_frs_102_section_1a_v1_1_3 companies_house Software false true true true No description of principal activity false true xbrli:pure xbrli:shares iso4217:GBP 10731782 2024-04-01 2025-03-31 10731782 2025-03-31 10731782 2024-03-31 10731782 core:WithinOneYear 2025-03-31 10731782 core:WithinOneYear 2024-03-31 10731782 core:ShareCapital 2025-03-31 10731782 core:ShareCapital 2024-03-31 10731782 bus:Director1 2024-04-01 2025-03-31 10731782 bus:RegisteredOffice 2024-04-01 2025-03-31 10731782 2023-04-01 2024-03-31 10731782 1 2024-04-01 2025-03-31 10731782 countries:EnglandWales 2024-04-01 2025-03-31 10731782 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10731782 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10731782 bus:SmallEntities 2024-04-01 2025-03-31 10731782 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number:
10731782
Bridgedale Medical Services Limited
Unaudited Filleted Financial Statements for the year ended
31 March 2025
Forshaws Accountants Limited
Chartered Accountants
Railex Business Centre, Crossens Way, Marine Drive, Southport, Merseyside, PR9 9LY, United Kingdom
Bridgedale Medical Services Limited
Chartered accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Bridgedale Medical Services Limited
Year ended
31 March 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements
of
Bridgedale Medical Services Limited
for the year ended
31 March 2025
which comprise the income statement, statement of income and retained earnings, statement of financial position and related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at icaew.com/​regulations.
This report is made solely to the Board of Directors of
Bridgedale Medical Services Limited
, as a body. Our work has been undertaken solely to prepare for your approval the
financial statements
of
Bridgedale Medical Services Limited
and state those matters that we have agreed to state to the Board of Directors of
Bridgedale Medical Services Limited
, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than
Bridgedale Medical Services Limited
and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that
Bridgedale Medical Services Limited
has kept adequate accounting records and to prepare statutory
financial statements
that give a true and fair view of the assets, liabilities, financial position and profit of
Bridgedale Medical Services Limited
. You consider that
Bridgedale Medical Services Limited
is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Bridgedale Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Forshaws Accountants Limited
Chartered Accountants
Railex Business Centre, Crossens Way
Marine Drive
Southport
Merseyside
PR9 9LY
United Kingdom
Date:
24 November 2025
Bridgedale Medical Services Limited
Statement of Financial Position
31 March 2025

|  | 2025 | 2024
--- | --- | --- | ---
| Note | £ | £
Current assets |  |  |  |  |
Debtors | 5 | 116,198 |  | 186,077 |
Cash at bank and in hand |  | 440,128 |  | 294,690 |
|  | 556,326 |  | 480,767 |
Creditors: amounts falling due within one year | 6 | (556,026 | ) | (480,467 | )
Net current assets |  | 300 |  | 300 |
Total assets less current liabilities |  | 300 |  | 300 |
Capital and reserves |  |  |  |  |
Called up share capital |  | 300 |  | 300 |
Profit and loss account |  | - |  | - |
Shareholders funds |  | 300 |  | 300 |

For the year ending
31 March 2025
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
24 November 2025
, and are signed on behalf of the board by:

Dr David Albert Waide
Director

Company registration number:
10731782
Bridgedale Medical Services Limited
Notes to the Financial Statements
Year ended
31 March 2025

## 1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
194 Victoria Road
,
Walton-Le-Dale
,
Preston
,
PR5 4AY
, United Kingdom.
The principal activity of the company is that of providing general medical services.

## 2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

## 3 Accounting policies

## Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

## Going concern

The Directors believe the company is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

## Turnover

When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period.
When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

## Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

## 4 Average number of employees

The average number of persons employed by the company during the year was
17
(2024:
9
).

## 5 Debtors

| 2025 | 2024
--- | --- | ---
| £ | £
Trade debtors | 115,898 |  | 185,777 |
Other debtors | 300 |  | 300 |
| 116,198 |  | 186,077 |

## 6 Creditors: amounts falling due within one year

| 2025 | 2024
--- | --- | ---
| £ | £
Amounts owed to group undertakings and undertakings in which the company has a participating interest | 84,355 |  | 85,685 |
Taxation and social security | - |  | 6,636 |
Other creditors | 471,671 |  | 388,146 |
| 556,026 |  | 480,467 |

## 7 Related party transactions

During the year the company entered into the following transactions with related parties:

| 2025 | 2024
--- | --- | ---
| £ | £
Amounts due to practices under the control of the Directors | 64,806 |  | 71,469 |
Amounts due to Shareholders | 6,595 |  | 6,595 |

At the balance sheet date, both amounts due to practices under the common control of the Directors and amounts due to Shareholders were unsecured, interest free and repayable on demand. All transactions with related parties are deemed to be conduced on an arm's length basis.

## 8 Controlling party

The company is not under the control of any one individual.